These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26863879)

  • 1. Design and Synthesis of Some Novel Estrogen Receptor Modulators as Anti-Breast Cancer Agents: In Vitro & In Vivo Screening, Docking Analysis.
    Dube PN; Mokale SN
    Anticancer Agents Med Chem; 2016; 16(11):1461-1467. PubMed ID: 26863879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Biological Investigation and Docking Study of Novel Chromen Derivatives as Anti-Cancer Agents.
    Dube PN; Sakle NS; Dhawale SA; More SA; Mokale SN
    Anticancer Agents Med Chem; 2019; 19(9):1150-1160. PubMed ID: 30848213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and anticancer screening of 3-(3-(substituted phenyl) acryloyl)-2H-chromen-2ones as selective anti-breast cancer agent.
    Mokale SN; Begum A; Sakle NS; Shelke VR; Bhavale SA
    Biomed Pharmacother; 2017 May; 89():966-972. PubMed ID: 28292025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.
    Lloyd DG; Smith HM; O'Sullivan T; Zisterer DM; Meegan MJ
    Med Chem; 2005 Jul; 1(4):335-53. PubMed ID: 16789891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
    Kurtanović N; Tomašević N; Matić S; Mitrović MM; Kostić DA; Sabatino M; Antonini L; Ragno R; Mladenović M
    Eur J Med Chem; 2022 Jan; 227():113869. PubMed ID: 34710747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells.
    Meegan MJ; Barrett I; Zimmermann J; Knox AJ; Zisterer DM; Lloyd DG
    J Enzyme Inhib Med Chem; 2007 Oct; 22(5):655-66. PubMed ID: 18035834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators.
    Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
    Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in Vitro, and in Vivo Biological Evaluation and Molecular Docking Analysis of Novel 3-(3-oxo-substitutedphenyl-3-)4-(2-(piperidinyl)ethoxy)phenyl)propyl)-2H-chromen-2-one Derivatives as Anti-breast Cancer Agents.
    Dube PN; Waghmare MN; Mokale SN
    Chem Biol Drug Des; 2016 Apr; 87(4):608-17. PubMed ID: 26643017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
    Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids.
    Mendoza-Sanchez R; Cotnoir-White D; Kulpa J; Jutras I; Pottel J; Moitessier N; Mader S; Gleason JL
    Bioorg Med Chem; 2015 Dec; 23(24):7597-606. PubMed ID: 26613635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent.
    Mokale SN; Sakle NS; Bhavale SA; Lokwani DK; Shelke VR
    Anticancer Agents Med Chem; 2018; 18(7):1009-1015. PubMed ID: 29189180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer.
    Liu G; Yin T; Kim H; Ding C; Yu Z; Wang H; Chen H; Yan R; Wold EA; Zou H; Liu X; Ding Y; Shen Q; Zhou J
    Eur J Med Chem; 2019 Sep; 178():589-605. PubMed ID: 31220676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Pyrazole-Chalcone Hybrids: Synthesis and Computational Insights Against Breast Cancer.
    Dabhade PS; Dabhade MP; Rathod LS; Dhawale SA; More SA; Chaudhari SY; Mokale SN
    Chem Biodivers; 2024 Jul; 21(7):e202400015. PubMed ID: 38705852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents.
    Sabbah DA; Ibrahim AH; Talib WH; Alqaisi KM; Sweidan K; Bardaweel SK; Sheikha GA; Zhong HA; Al-Shalabi E; Khalaf RA; Mubarak MS
    Med Chem; 2019; 15(4):417-429. PubMed ID: 30207238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of benzofuranone library via a metal-free, one-pot intermolecular condensation, and their application as efficient estrogen receptor β modulators.
    Peng X; Hu Z; Zhang J; Ning W; Zhang S; Dong C; Shi X; Zhou HB
    Chem Commun (Camb); 2019 Dec; 55(97):14570-14573. PubMed ID: 31660550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.